Cargando…
Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus
Early identification of patients at risk of developing diabetic nephropathy is essential. Elevated serum concentrations of soluble urokinase receptor (suPAR) associate with diabetes mellitus and predict onset and loss of renal function in chronic kidney disease. We hypothesize, that suPAR may be an...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238426/ https://www.ncbi.nlm.nih.gov/pubmed/28091558 http://dx.doi.org/10.1038/srep40627 |
_version_ | 1782495704047943680 |
---|---|
author | Guthoff, Martina Wagner, Robert Randrianarisoa, Elko Hatziagelaki, Erifili Peter, Andreas Häring, Hans-Ulrich Fritsche, Andreas Heyne, Nils |
author_facet | Guthoff, Martina Wagner, Robert Randrianarisoa, Elko Hatziagelaki, Erifili Peter, Andreas Häring, Hans-Ulrich Fritsche, Andreas Heyne, Nils |
author_sort | Guthoff, Martina |
collection | PubMed |
description | Early identification of patients at risk of developing diabetic nephropathy is essential. Elevated serum concentrations of soluble urokinase receptor (suPAR) associate with diabetes mellitus and predict onset and loss of renal function in chronic kidney disease. We hypothesize, that suPAR may be an early risk indicator for diabetic nephropathy, preceding microalbuminuria. The relationship of baseline suPAR and incident microalbuminuria was assessed in a prospective long-term cohort of subjects at increased risk for type 2 diabetes (TULIP, n = 258). Association with albuminuria at later stages of disease was studied in a cross-sectional cohort with manifest type 2 diabetes (ICEPHA, n = 266). A higher baseline suPAR was associated with an increased risk of new-onset microalbuminuria in subjects at risk for type 2 diabetes (hazard ratio 5.3 (95% CI 1.1–25.2, p = 0.03) for the highest vs. lowest suPAR quartile). The proportion of subjects with prediabetes at the end of observation was higher in subjects with new-onset microalbuminuria. suPAR consistently correlated with albuminuria in a separate cohort with manifest type 2 diabetes. Elevated baseline suPAR concentrations independently associate with new-onset microalbuminuria in subjects at increased risk of developing type 2 diabetes. suPAR may hence allow for earlier risk stratification than microalbuminuria. |
format | Online Article Text |
id | pubmed-5238426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-52384262017-01-19 Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus Guthoff, Martina Wagner, Robert Randrianarisoa, Elko Hatziagelaki, Erifili Peter, Andreas Häring, Hans-Ulrich Fritsche, Andreas Heyne, Nils Sci Rep Article Early identification of patients at risk of developing diabetic nephropathy is essential. Elevated serum concentrations of soluble urokinase receptor (suPAR) associate with diabetes mellitus and predict onset and loss of renal function in chronic kidney disease. We hypothesize, that suPAR may be an early risk indicator for diabetic nephropathy, preceding microalbuminuria. The relationship of baseline suPAR and incident microalbuminuria was assessed in a prospective long-term cohort of subjects at increased risk for type 2 diabetes (TULIP, n = 258). Association with albuminuria at later stages of disease was studied in a cross-sectional cohort with manifest type 2 diabetes (ICEPHA, n = 266). A higher baseline suPAR was associated with an increased risk of new-onset microalbuminuria in subjects at risk for type 2 diabetes (hazard ratio 5.3 (95% CI 1.1–25.2, p = 0.03) for the highest vs. lowest suPAR quartile). The proportion of subjects with prediabetes at the end of observation was higher in subjects with new-onset microalbuminuria. suPAR consistently correlated with albuminuria in a separate cohort with manifest type 2 diabetes. Elevated baseline suPAR concentrations independently associate with new-onset microalbuminuria in subjects at increased risk of developing type 2 diabetes. suPAR may hence allow for earlier risk stratification than microalbuminuria. Nature Publishing Group 2017-01-16 /pmc/articles/PMC5238426/ /pubmed/28091558 http://dx.doi.org/10.1038/srep40627 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Guthoff, Martina Wagner, Robert Randrianarisoa, Elko Hatziagelaki, Erifili Peter, Andreas Häring, Hans-Ulrich Fritsche, Andreas Heyne, Nils Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus |
title | Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus |
title_full | Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus |
title_fullStr | Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus |
title_full_unstemmed | Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus |
title_short | Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus |
title_sort | soluble urokinase receptor (supar) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238426/ https://www.ncbi.nlm.nih.gov/pubmed/28091558 http://dx.doi.org/10.1038/srep40627 |
work_keys_str_mv | AT guthoffmartina solubleurokinasereceptorsuparpredictsmicroalbuminuriainpatientsatriskfortype2diabetesmellitus AT wagnerrobert solubleurokinasereceptorsuparpredictsmicroalbuminuriainpatientsatriskfortype2diabetesmellitus AT randrianarisoaelko solubleurokinasereceptorsuparpredictsmicroalbuminuriainpatientsatriskfortype2diabetesmellitus AT hatziagelakierifili solubleurokinasereceptorsuparpredictsmicroalbuminuriainpatientsatriskfortype2diabetesmellitus AT peterandreas solubleurokinasereceptorsuparpredictsmicroalbuminuriainpatientsatriskfortype2diabetesmellitus AT haringhansulrich solubleurokinasereceptorsuparpredictsmicroalbuminuriainpatientsatriskfortype2diabetesmellitus AT fritscheandreas solubleurokinasereceptorsuparpredictsmicroalbuminuriainpatientsatriskfortype2diabetesmellitus AT heynenils solubleurokinasereceptorsuparpredictsmicroalbuminuriainpatientsatriskfortype2diabetesmellitus |